Johnson & Johnson’s most recent trend suggests a bullish bias. One trading opportunity on Johnson & Johnson is a Bull Put Spread using a strike $90.00 short put and a strike $85.00 long put offers a potential 11.61% return on risk over the next 26 calendar days. Maximum profit would be generated if the Bull Put Spread were to expire worthless, which would occur if the stock were above $90.00 by expiration. The full premium credit of $0.52 would be kept by the premium seller. The risk of $4.48 would be incurred if the stock dropped below the $85.00 long put strike price.
The 5-day moving average is moving up which suggests that the short-term momentum for Johnson & Johnson is bullish and the probability of a rise in share price is higher if the stock starts trending.
The 20-day moving average is moving up which suggests that the medium-term momentum for Johnson & Johnson is bullish.
The RSI indicator is at 67.85 level which suggests that the stock is neither overbought nor oversold at this time.
To learn how to execute such a strategy while accounting for risk and reward in the context of smart portfolio management, and see how to trade live with a successful professional trader, view more here
LATEST NEWS for Johnson & Johnson
Johnson & Johnson and UnitedHealth Take Down the Dow
Mon, 21 Oct 2013 18:36:17 GMT
Motley Fool – The Dow Jones gets off to a slow start as Johnson & Johnson and UnitedHealth can’t stay out of the red after last week’s wildly different earnings reports.
Gilead and Johnson & Johnson Face the FDA
Mon, 21 Oct 2013 18:34:05 GMT
Motley Fool – Both Gilead and Johnson & Johnson have advisory committee meetings this week for their hepatitis C drugs that will be used in combination with injected drugs from Merck and Roche. Neither looks like much …
McDonald’s Signals Weak Q4 Global Established Restaurant Sales and 2 Other Dow Movers to Watch
Mon, 21 Oct 2013 17:40:21 GMT
Wall St. Cheat Sheet – These stocks are moving the Dow now.
One Put, One Call Option To Know About for Johnson & Johnson
Mon, 21 Oct 2013 15:59:00 GMT
Forbes – Consistently, one of the more popular stocks people enter into their stock options watchlist at Stock Options Channel is Johnson & Johnson (NYSE: JNJ). So this week we highlight one interesting put contract, and one interesting call contract, from the November expiration for JNJ. The put contract our YieldBoost algorithm identified […]
3 Stocks to Rule the Next Decade of Diabetes Treatments
Sun, 20 Oct 2013 14:10:20 GMT
Motley Fool – Merck, Sanofi, and Novo Nordisk hold court among suitors to diabetes’ growing global market.
Also on Market Tamer…
Follow Us on Facebook